Liver gene expression in rats in response to the peroxisome proliferator-activated receptor-alpha agonist ciprofibrate.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Physiological Genomics

• Publication date

  2003-09-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1152/PHYSIOLGENOMICS.00064.2003PMID 12851464
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dietary polyunsaturated fatty acids and hepatic gene expression

  2007cited by this paper
• Nuclear receptors and the control of metabolism.

  2003cited by this paper
• Gene expression profile in the regenerating rat liver after partial hepatectomy.

  2003cited by this paper
• The peroxisome proliferator-activated receptor α (PPARα): role in hepatocarcinogenesis

  2002cited by this paper
• Comparison of different labeling methods for two-channel high-density microarray experiments.

  2002cited by this paper
• p8 is critical for tumour development induced by rasV12 mutated protein and E1A oncogene

  2002cited by this paper
• Gene Expression Omnibus: NCBI gene expression and hybridization array data repository

  2002cited by this paper
• SAGE identification of gene transcripts with profiles unique to pluripotent mouse R1 embryonic stem cells.

  2002cited by this paper
• Peroxisome Proliferator-activated Receptor α (PPARα) Influences Substrate Utilization for Hepatic Glucose Production*

  2002cited by this paper
• Microarray analysis of gene expression changes in mouse liver induced by peroxisome proliferator- activated receptor alpha agonists.

  2002cited by this paper
• Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

  2002cited by this paper
• Peroxisome proliferator-activated receptor alpha (PPARalpha) influences substrate utilization for hepatic glucose production.

  2002cited by this paper
• Microarray comparison of normal and W/Wv mice in the gastric fundus indicates a supersensitive phenotype.

  2002cited by this paper
• The peroxisome proliferator-activated receptor alpha (PPARalpha): role in hepatocarcinogenesis.

  2002cited by this paper
• Fundamentals of experimental design for cDNA microarrays

  2002cited by this paper
• Identification of novel peroxisome proliferator-activated receptor alpha (PPARalpha) target genes in mouse liver using cDNA microarray analysis.

  2001influential reference
• Gene transcription in hepatocytes during the acute phase of a systemic inflammation: from transcription factors to target genes

  2001cited by this paper
• The IGF axis and hepatocarcinogenesis

  2001cited by this paper
• Rat PPARs: Quantitative Analysis in Adult Rat Tissues and Regulation in Fasting and Refeeding.

  2001cited by this paper
• The peroxisome proliferator‐activated receptor α regulates amino acid metabolism

  2001cited by this paper
• Minimum information about a microarray experiment (MIAME)—toward standards for microarray data

  2001cited by this paper
• Profiling and verification of gene expression patterns in normal and malignant human prostate tissues by cDNA microarray analysis.

  2001cited by this paper
• Expression of p8 in human pancreatic cancer.

  2001cited by this paper
• The ligands/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma increase Cu2+,Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells.

  2001cited by this paper
• The ligands/activators for peroxisome proliferator-activated receptor α (PPARα) and PPARγ increase Cu2+, Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells

  2001cited by this paper
• Regulation of the liver fatty acid-binding protein gene by hepatocyte nuclear factor 1alpha (HNF1alpha). Alterations in fatty acid homeostasis in HNF1alpha-deficient mice.

  2000cited by this paper
• Regulation of the Liver Fatty Acid-binding Protein Gene by Hepatocyte Nuclear Factor 1α (HNF1α)

  2000cited by this paper
• Central role of PPARalpha in the mechanism of action of hepatocarcinogenic peroxisome proliferators.

  2000cited by this paper
• Expression of base excision repair enzymes in rat and mouse liver is induced by peroxisome proliferators and is dependent upon carcinogenic potency.

  2000cited by this paper
• Octreotide inhibits the enterochromaffin-like cell but not peroxisome proliferator-induced hypergastrinemia.

  2000cited by this paper
• A novel, sensitive detection system for high-density microarrays using dendrimer technology.

  2000influential reference
• PPARα Agonists Reduce 11β-Hydroxysteroid Dehydrogenase Type 1 in the Liver

  2000influential reference
• PPARalpha agonists reduce 11beta-hydroxysteroid dehydrogenase type 1 in the liver.

  2000influential reference
• Regulation of the Liver Fatty Acid-binding Protein Gene by Hepatocyte Nuclear Factor 1α (HNF1α) ALTERATIONS IN FATTY ACID HOMEOSTASIS INHNF1α-DEFICIENT MICE

  2000cited by this paper
• Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis.

  2000cited by this paper
• Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting

  1999cited by this paper
• Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1*

  1999cited by this paper
• Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting.

  1999cited by this paper
• Expression of a novel factor in human breast cancer cells with metastatic potential.

  1999cited by this paper
• Hepatic expression of acute‐phase protein genes during carcinogenesis induced by peroxisome proliferators

  1999cited by this paper
• A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders.

  1999cited by this paper
• A critical role for the peroxisome proliferator-activated receptor a (PPAR a ) in the cellular fasting response: The PPAR a -null mouse as a model of fatty acid oxidation disorders

  1999cited by this paper
• Peroxisome proliferator-activated receptors: nuclear control of metabolism.

  1999influential reference
• Peroxisome proliferator-activated receptor alpha: role in rodent liver cancer and species differences.

  1999cited by this paper
• Role of peroxisome proliferator-activated receptor alpha in altered cell cycle regulation in mouse liver.

  1998cited by this paper
• Down-regulation of cytochrome P450 2C family members and positive acute-phase response gene expression by peroxisome proliferator chemicals.

  1998cited by this paper
• cDNA cloning and genomic organization of peroxisome proliferator-inducible long-chain acyl-CoA hydrolase from rat liver cytosol.

  1998influential reference
• Cloning and Characterization of a Novel Binding Factor (GMEB-2) of the Glucocorticoid Modulatory Element*

  1998cited by this paper
• Strain-dependent embryonic lethality in mice lacking the retinoblastoma-related p130 gene.

  1998cited by this paper
• Suppression of Leukotriene B4 Biosynthesis by Endogenous Adenosine in Ligand-activated Human Neutrophils

  1997cited by this paper
• Growth-inhibitory Activity and Downregulation of the Class II Tumor-suppressor Gene H-rev107 in Tumor Cell Lines and Experimental Tumors

  1997cited by this paper
• Cloning and Expression of the Rat p8 cDNA, a New Gene Activated in Pancreas during the Acute Phase of Pancreatitis, Pancreatic Development, and Regeneration, and Which Promotes Cellular Growth*

  1997cited by this paper
• Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ

  1997cited by this paper
• Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta.

  1997cited by this paper
• Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism.

  1997influential reference
• The PPARα–leukotriene B4 pathway to inflammation control

  1996cited by this paper
• Effect on the expression of c-met, c-myc and PPAR-alpha in liver and liver tumors from rats chronically exposed to the hepatocarcinogenic peroxisome proliferator WY-14,643.

  1996cited by this paper
• The PPARalpha-leukotriene B4 pathway to inflammation control.

  1996cited by this paper
• Discordant expression of the cyclin-dependent kinases and cyclins in rat liver following acute administration of the hepatocarcinogen [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (WY14,643).

  1996cited by this paper
• Liver‐enriched transcription factors and hepatocyte differentiation

  1996cited by this paper
• Adenosine A2 receptor‐induced inhibition of leukotriene B4 synthesis in whole blood ex vivo

  1996cited by this paper
• Role of the peroxisome proliferator‐activated receptor in cytochrome P450 4A gene regulation

  1996cited by this paper
• Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators

  1995cited by this paper
• 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase: a metabolic signaling enzyme.

  1995cited by this paper
• Ornithine decarboxylase as a target for chemoprevention

  1995cited by this paper
• Subtraction cloning of H-rev107, a gene specifically expressed in H-ras resistant fibroblasts.

  1994cited by this paper
• YB-1 DNA-binding protein represses interferon gamma activation of class II major histocompatibility complex genes

  1994cited by this paper
• Mechanistically-based Human Hazard Assessment of Peroxisome Proliferator-induced Hepatocarcinogenesis

  1994cited by this paper
• Changes in Human & Experimental Toxicology

  1994cited by this paper
• Peroxisome proliferators: paradigms and prospects.

  1993cited by this paper
• Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors

  1992cited by this paper
• Activation of the gadd153 promoter by genotoxic agents: a rapid and specific response to DNA damage.

  1992cited by this paper
• Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors.

  1992cited by this paper
• Contrasting hepatocytic peroxisome proliferation, lipofuscin accumulation and cell turnover for the hepatocarcinogens Wy-14,643 and clofibric acid.

  1992cited by this paper
• The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene.

  1992influential reference
• Two cis-acting regulatory sequences in the peroxisome proliferator-responsive enhancer region of rat acyl-CoA oxidase gene.

  1991cited by this paper
• Interleukin 6 is a negative regulator of the acute phase alpha 1-inhibitor III gene.

  1990cited by this paper
• Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

  1990cited by this paper
• Biochemical mechanisms of induction of hepatic peroxisome proliferation.

  1989cited by this paper
• Molecular and genetic analysis of cystic fibrosis.

  1988cited by this paper
• Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats.

  1988influential reference
• Purified hepatocyte nuclear factor 1 interacts with a family of hepatocyte-specific promoters.

  1988cited by this paper
• Cloning, sequencing, and regulation of rat liver carnitine octanoyltransferase: transcriptional stimulation of the enzyme during peroxisome proliferation.

  1988cited by this paper
• DNA damage related to increased hydrogen peroxide generation by hypolipidemic drug-induced liver peroxisomes.

  1984cited by this paper
• Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens

  1980influential reference
• Mitogenic and carcinogenic effects of a hypolipidemic peroxisome proliferator, [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14, 643), in rat and mouse liver.

  1979influential reference

• RAID: Regression Analysis–Based Inductive DNA Microarray for Precise Read-Across

  2022cites this paper
• Integrative Toxicogenomics: Analytical Strategies to Amalgamate Exposure Effects With Genomic Sciences

  2019cites this paper
• Crosstalk between Receptor and Non-receptor Mediated Chemical Modes of Action in Rat Livers Converges through a Dysregulated Gene Expression Network at Tumor Suppressor Tp53

  2017cites this paper
• Mechanism of action of anti-hypercholesterolemia drugs and their resistance.

  2014cites this paper
• Beyond Statins: Lipid Management to Reduce Cardiovascular Risk

  2013cites this paper
• Liver and Pancreas

  2012cites this paper
• Gene expression‐based in vivo and in vitro prediction of liver toxicity allows compound selection at an early stage of drug development

  2011cites this paper
• Mechanism of action of liver growth induced by peroxisome proliferators

  2010cites this paper
• Peroxisome proliferator-activated receptora (PPARa) agonists down-regulate a2-macroglobulin expression by a PPARa-dependent mechanism q

  2009cites this paper
• Toxicogenomic Biomarkers for Liver Toxicity

  2009cites this paper
• Peroxisome proliferator-activated receptor a ( PPAR a ) agonists downregulate a 2-macroglobulin expression by a PPAR a-dependent mechanism q Marı́a

  2009cites this paper
• Peroxisome proliferator-activated receptor alpha (PPARalpha) agonists down-regulate alpha2-macroglobulin expression by a PPARalpha-dependent mechanism.

  2009cites this paper
• Role of Esrrg in the fibrate-mediated regulation of lipid metabolism genes in human ApoA-I transgenic mice

  2009cites this paper
• Augmenting Bioinformatics Research with Biomedical Ontologies

  2008cites this paper
• The PPAR alpha-humanized mouse: a model to investigate species differences in liver toxicity mediated by PPAR alpha.

  2008cites this paper
• Non-alcoholic steatohepatitis : second hit or strike out?

  2008cites this paper
• Changes in gene expression of gastric mucosa during therapeutic acid inhibition

  2008cites this paper
• The PPARα-Humanized Mouse: A Model to Investigate Species Differences in Liver Toxicity Mediated by PPARα

  2008influential citation
• Identification of novel neuroendocrine-specific tumour genes

  2008cites this paper
• Acute hepatotoxicity: a predictive model based on focused illumina microarrays.

  2007cites this paper
• 9 – Liver and Pancreas

  2007cites this paper
• Exploration of PPAR functions by microarray technology--a paradigm for nutrigenomics.

  2007cites this paper
• Genomic Profiling in Nuclear Receptor-Mediated Toxicity

  2007cites this paper
• Physiological genomics of heart failure : from technology to physiology.

  2007cites this paper
• Quantification and regulation of the subcellular distribution of bile acid coenzyme A:amino acid N-acyltransferase activity in rat liver Published, JLR Papers in Press, March 22, 2007.

  2007cites this paper
• Rat Liver Peroxisomes after Fibrate Treatment

  2007cites this paper
• Appraisal of state-of-the art Systems-ADME/Tox: Resources and network approaches

  2006influential citation
• Cross-species comparative toxicogenomics as an aid to safety assessment

  2006cites this paper
• PPARalpha and PPARgamma regulation of liver and adipose proteins in obese and dyslipidemic rodents.

  2006cites this paper
• Gene expression profiles in fathead minnow exposed to 2,4-DNT: correlation with toxicity in mammals.

  2006cites this paper
• Assessing the Reliability of Amplified RNA Used in Microarrays

  2006cites this paper
• Systems-ADME/Tox: resources and network approaches.

  2006cites this paper
• Genome-wide identification of peroxisome proliferator response elements using integrated computational genomics s⃞ Published, JLR Papers in Press, April 3, 2006.

  2006cites this paper
• Comparative analysis of parametric, nonparametric and permutation methods for differential expression

  2006cites this paper
• Differential induction of genes in liver and brown adipose tissue regulated by peroxisome proliferator-activated receptor-alpha during fasting and cold exposure in acyl-CoA dehydrogenase-deficient mice.

  2005cites this paper
• Gene ontology mapping as an unbiased method for identifying molecular pathways and processes affected by toxicant exposure: application to acute effects caused by the rodent non-genotoxic carcinogen diethylhexylphthalate.

  2005cites this paper
• Molecular characterization of rat gastric mucosal response to potent acid inhibition.

  2005cites this paper
• Identification of novel growth factor-responsive genes in neuroendocrine gastrointestinal tumour cells

  2005influential citation
• Gene expression profiling of the PPAR-alpha agonist ciprofibrate in the cynomolgus monkey liver.

  2005cites this paper
• Fenofibric Acid, an Active Form of Fenofibrate, Increases Apolipoprotein A-I–Mediated High-Density Lipoprotein Biogenesis by Enhancing Transcription of ATP-Binding Cassette Transporter A1 Gene in a Liver X Receptor–Dependent Manner

  2005cites this paper
• Gene expression based classification of gastric carcinoma.

  2004cites this paper
• Miniaturized fluorescent RNA dot blot method for rapid quantitation of gene expression

  2004cites this paper
• Liver-Enriched Transcription Factors in Liver Function and Development. Part II: the C/EBPs and D Site-Binding Protein in Cell Cycle Control, Carcinogenesis, Circadian Gene Regulation, Liver Regeneration, Apoptosis, and Liver-Specific Gene Regulation

  2004cites this paper
• Towards Automated Explanation of Gene-Gene Relationships

  2003cites this paper